Search by Drug Name or NDC
NDC 00206-8860-02 Zosyn 2; 250 g/50mL; mg/50mL Details
Zosyn 2; 250 g/50mL; mg/50mL
Zosyn is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.. The primary component is PIPERACILLIN SODIUM; TAZOBACTAM SODIUM.
MedlinePlus Drug Summary
Piperacillin and tazobactam injection is used to treat pneumonia and skin, gynecological, and abdominal (stomach area) infections caused by bacteria. Piperacillin is in a class of medications called penicillin antibiotics. It works by killing bacteria that cause infection. Tazobactam is in a class called beta-lactamase inhibitor. It works by preventing bacteria from destroying piperacillin. Antibiotics such as piperacillin and tazobactam injection will not work for colds, flu, or other viral infections. Taking or using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
Related Packages: 00206-8860-02Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Piperacillin and Tazobactam Injection
Product Information
| NDC | 00206-8860 |
|---|---|
| Product ID | 0206-8860_30496b61-307a-43af-8369-971593382a70 |
| Associated GPIs | 01990002722020 |
| GCN Sequence Number | 040817 |
| GCN Sequence Number Description | piperacillin-tazo-dextrose,iso FROZ.PIGGY 2.25G/50ML INTRAVEN |
| HIC3 | W1A |
| HIC3 Description | PENICILLIN ANTIBIOTICS |
| GCN | 53285 |
| HICL Sequence Number | 032900 |
| HICL Sequence Number Description | PIPERACILLIN AND TAZOBACTAM IN DEXTROSE, ISO-OSMOTIC |
| Brand/Generic | Brand |
| Proprietary Name | Zosyn |
| Proprietary Name Suffix | in Galaxy Containers |
| Non-Proprietary Name | TAZOBACTAM SODIUM and PIPERACILLIN SODIUM |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 2; 250 |
| Active Ingredient Units | g/50mL; mg/50mL |
| Substance Name | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM |
| Labeler Name | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. |
| Pharmaceutical Class | Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA050750 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00206-8860-02 (00206886002)
| NDC Package Code | 0206-8860-02 |
|---|---|
| Billing NDC | 00206886002 |
| Package | 24 BAG in 1 BOX (0206-8860-02) / 50 mL in 1 BAG (0206-8860-01) |
| Marketing Start Date | 1998-03-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |